<DOC>
	<DOC>NCT01986621</DOC>
	<brief_summary>This pilot study aims to identify patients at moderate to high risk for peri-procedural (type 4) myocardial infarction or injury after after undergoing an elective coronary intervention (PCI) as measured by high sensitivity troponin T, who might benefit from more potent antiplatelet therapy.</brief_summary>
	<brief_title>Myocardial Injury or Type 4 Infarction Following Elective Coronary Artery Stenting</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<criteria>Stable or unknown coronary artery disease (CAD) Elective coronary intervention Minimum age of 18 Present acute coronary syndrome (ACS) Age under 18 Pregnancy Any additional invasive intervention with potential myocardial injury Non ACS conditions responsible for elevation of cardiac troponin, such as acute pulmonary artery embolism, myocarditis or tachycardia. Procedure related complications leading to troponin elevations (e.g. coronary dissection)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>